These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7569150)

  • 21. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy.
    Luciano AA; De Souza MJ; Roy MP; Schoenfeld MJ; Nulsen JC; Halvorson CV
    J Reprod Med; 1993 Mar; 38(3):207-14. PubMed ID: 8487239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
    Byrjalsen I; Thormann L; Meinecke B; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Apr; 79(4):523-8. PubMed ID: 1532445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study between estradiol valerate combined with cyproterone acetate, and conjugated equine estrogens combined with medroxyprogesterone acetate as hormone replacement therapy in climacteric].
    Carranza-Lira S; Martínez-Chéquer JC; Río de la Loza F; Murillo-Uribe A; Celis C
    Ginecol Obstet Mex; 2000 Nov; 68():442-7. PubMed ID: 11195956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women.
    Dören M; Reuther G; Minne HW; Schneider HP
    Am J Obstet Gynecol; 1995 Nov; 173(5):1446-51. PubMed ID: 7503183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha-Tocopherol and beta-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate.
    Clemente C; Caruso MG; Berloco P; Buonsante A; Giannandrea B; Di Leo A
    Horm Metab Res; 1996 Oct; 28(10):558-61. PubMed ID: 8934216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidants.
    Tranquilli AL; Mazzanti L; Cugini AM; Cester N; Garzetti GG; Romanini C
    Gynecol Endocrinol; 1995 Jun; 9(2):137-41. PubMed ID: 7502690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
    Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
    Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens.
    Heikkinen J; Vaheri R; Kainulainen P; Timonen U
    Osteoporos Int; 2000; 11(11):929-37. PubMed ID: 11193245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol and norgestimate: a review of their combined use as hormone replacement therapy in postmenopausal women.
    Curran MP; Wagstaff AJ
    Drugs Aging; 2001; 18(11):863-85. PubMed ID: 11772126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study.
    Gräser T; Müller A; Mellinger U; Mück AO; Lippert TH; Oettel M
    Maturitas; 2000 Jun; 35(3):253-61. PubMed ID: 10936742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monitoring the breast changes of Chinese postmenopausal women under long-term hormone replacement therapy by mammary ultrasonography].
    Huang MT; Jiang YX; Lin SQ; Zhang Y; Zhou YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):24-9. PubMed ID: 15052769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Climodien (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints.
    Gräser T; Römer T; Wiedey KD; Janaud A
    Climacteric; 2001 Dec; 4(4):332-42. PubMed ID: 11770190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.